AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-187460968/invitrogen-form-10-q.html" title="Facts and information about Invitrogen Form 10-Q Interim Report 2Q and 1H 2008: Segment information: Cell Systems.">Invitrogen Form 10-Q Interim Report 2Q and 1H 2008: Segment information: Cell Systems.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Invitrogen Form 10-Q Interim Report 2Q and 1H 2008: Segment information: Cell Systems.
For its 2Q 2008 (period ends 30 Jun 2008), the Cell Systems segment of Invitrogen Corp has reported revenues of $114.7 M ($98.9 M for its 2Q 2007), R&D expenditure of $4.1 M ($3.6 M) and operating income of $25.6 M ($19.9 M). For its 1H 2008, this segment has reported revenues of $217.6 M ($187.5 M for its 1H 2007), R&D expenditure of $6.6 M ($47.2 M) and operating income of $49.7 M ($36.7 M). The Cell Systems product segment …
Related articles from newspapers, magazines, journals, and more
